Bridgeway Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 1,300 shares of VRTX stock, worth $531,388. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,300

Previous 1,300 -0.0%

Holding current value

$531,388

Previous $609,000 0.82%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $2.4 Million - $2.96 Million	-6,100 Reduced 82.43%	1,300 $609,000
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $2.41 Million - $2.63 Million	-5,900 Reduced 44.36%	7,400 $3.09 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $2.74 Million - $3.29 Million	-8,000 Reduced 37.56%	13,300 $5.41 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $2.38 Million - $2.56 Million	-7,050 Reduced 24.87%	21,300 $7.41 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $764,721 - $872,370	2,700 Added 10.53%	28,350 $8.93 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $7.02 Million - $7.84 Million	25,650 New	25,650 $7.43 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $3.44 Million - $4.01 Million	-16,610 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $680,029 - $806,246	2,660 Added 19.07%	16,610 $4.52 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $784,670 - $1.03 Million	3,480 Added 33.24%	13,950 $4.05 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $2.09 Million - $2.59 Million	10,470 New	10,470 $2.49 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $1.15 Million - $1.33 Million	-7,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $2.16 Million - $2.57 Million	-13,200 Reduced 65.35%	7,000 $1.29 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $4.42 Million - $5.59 Million	-29,100 Reduced 59.03%	20,200 $3.35 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $7.3 Million - $8 Million	49,300	49,300 $7.5 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History